Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kyukyu Pharmaceutical is a private Japanese pharmaceutical manufacturer focused on patient-friendly dosage forms, particularly oral film formulations and transdermal/topical patch products. The company states that it developed and manufactured the world's first film preparations, including ODF (orally disintegrating film) and adhesive oral film formats, and it applies advanced coating and adhesion technologies across R&D and in-house production. Its commercial portfolio appears concentrated in OTC, quasi-drug, and ethical pharmaceutical products for pain, anti-inflammatory, anti-itch, and oral mucosal indications. Kyukyu also operates as a formulation-focused partner for larger Japanese pharma companies, with products distributed or transacted through companies such as Daiichi Sankyo Healthcare, Teikoku Pharmacare, Eisai, Mochida, Viatris, and Towa Pharmaceutical. Overall, the company looks more like a specialty formulation and manufacturing-focused pharma than a venture-stage discovery biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kyukyu Pharmaceutical.